Molecular and pharmacological detection of dopaminergic receptors in the human male urinary tract

Neurourology and Urodynamics

Volumn 28, Issue 4, 2009, Pages 343-348

  Arrighi, Nicola ^a   Bodei, Serena ^a   Zani, Danilo ^a   Simeone, Claudio ^a   Fiorentini, Chiara ^a   Missale, Cristina ^a   Milanese, Giulio ^b   Dellabella, Marco ^b   Muzzonigro, Giovanni ^b   Cunico, Sergio Cosciani ^a   Spano, Pier Franco ^a   Sigala, Sandra ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Dopamine receptors; Human; Male; Urinary tract

Indexed keywords

ADENYLATE CYCLASE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE 5 RECEPTOR; DOPAMINE RECEPTOR; MESSENGER RNA; RECEPTOR SUBTYPE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DENSITOMETRY; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC CODE; HUMAN; HUMAN TISSUE; MALE; MOLECULAR BIOLOGY; PROTEIN ANALYSIS; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; URETER; URETHRA; URINARY TRACT;

ADENYLATE CYCLASE; AGED; CYCLIC AMP; DOPAMINE AGENTS; HUMANS; MALE; MIDDLE AGED; PROSTATE; RECEPTORS, DOPAMINE; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; URETER; URETHRA; URINARY BLADDER; URINARY TRACT; URINARY TRACT PHYSIOLOGICAL PHENOMENA;

EID: 67649965206     PISSN: 07332467     EISSN: 15206777     Source Type: Journal    
DOI: 10.1002/nau.20652     Document Type: Article

References (24)

1. Andersson KE, Wein AJ. Pharmacology of the lower urinary tract: Basis for current and future treatments of urinary incontinence. Pharmacol Rev 2004; 56:581-631.
2. de Groat WC. Integrative control of the lower urinary tract: Preclinical perspective. Br J Pharmacol 2006;147:S25-40.
3. Seki S, Igawa Y, Kaidoh H, et al. Role of dopamine D1 and D2 receptors in the micturation reflex in conscious rats. Neurourol Urodyn 2001;20:105-13.
4. Ogawa T, Seki S, Masuda H, et al. Dopaminergic mechanism controlling urethral function in rats. Neurourol Urodyn 2006;25:480-9.
5. Missale C, Nash SR, Robinson SW, et al. Dopamine receptors: From structure to function. Physiol Rev 1998;78:189-225.
6. Escaf S, Cavallotti C, Ricci A, et al. Dopamine D1 and D2 receptors in the human ureter and urinary bladder: A radioligand binding and autographic study. Br J Urol 1994;473-9.
7. Kester RR, Mooppan UM, Gousse AE, et al. Pharmacological characterization of isolated human prostate. J Urol 2003;170:1032-8.
8. Ribeiro MJ, Ricard M, Bourgeois S, et al. Biodistribution and radiation dosimetry of [11C]raclopride in healthy volunteers. Eur J Nucl Med Mol Imaging 2005;32:952-8.
9. Cropley VL, Fujita M, Musachio JL, et al. Whole-body biodistribution and estimation of radiation-absorbed doses of the dopamine D1 receptor radioligand 11C-NNC 112 in humans. J Nucl Med 2006;47:100-4.
10. Spano PF, Govoni S, Trabucchi M. Studies on the pharmacological properties of dopamine receptors in various areas of the central nervous system. Adv Biochem Psychopharmacol 1978;19:155-9.
11. Kebabian JW, Calne DB. Multiple receptors for dopamine. Nature 1979;277:93-6.
12. Zhang W, Carriquiry A, Nettleton D, et al. Pooling mRNA in microarray experiments and its effect on power. Bioinformatics 2007;23:1217-24.
13. Sigala S, Dellabella M, Milanese G, et al. Evidence for the presence of alpha1 adrenoceptor subtypes in the human ureter. Neurourol Urodyn 2005;24: 142-8.
14. Arrighi N, Bodei S, Peroni A, et al. Detection of muscarinic receptor subtypes in human urinary bladder mucosa: Age and gender-dependent modifications. Neurourol Urodyn 2008;27:421-8.
15. Missale G, Missale C, Sigala S, et al. Evidence for the presence of both D-1 and D-2 dopamine receptors in human esophagus. Life Sci 1990;47:447-55.
16. d'Emmanuele diVilla Bianca R, Sorrentino R, Roviezzo F, et al. Peripheral relaxant activity of apomorphine and of a D1 selective receptor agonist on human corpus cavernosum strips. Int J Impot Res 2005;17:127-33.
17. Matsumoto K, Yoshida M, Andersson KE, et al. Effects in vitro and in vivo by apomorphine in the rat corpus cavernosum. Br J Pharmacol 2005;146:259-67.
18. Hyun JS, Baig MR, Yang DY, et al. Localization of peripheral dopamine D1 and D2 receptors in rat and human seminal vesicles. J Androl 2002;23: 114-20.
19. El-Mas M, Elmallah A, Omar A, et al. Dopamine modulates peripheral purinergic neurotransmission through multiple presynaptic receptors: Tissue-dependent effects. Pharmacol Res 1999;39: 11-9.
20. Rey-Ares V, Lazarov N, Berg D, et al. Dopamine receptor repertoire of human granulosa cells. Reprod Biol Endocrinol 2007;25:40.
21. O'Malley KL, Harmon S, Tang L, et al. The rat dopamine D4 receptor: Sequence, gene, structure and demonstration of expression in the cardiovascular system. New Biol 1992;4:137-46.
22. Bek MJ, Wang X, Asico LD, et al. Angiotensin-II type 1 receptor-mediated hypertension in D4 dopamine receptor-deficient mice. Hypertension 2006; 47:288-95.
23. Gazi L, Schoeffter P, Nunn C, et al. Cloning, expression, functional coupling and pharmacological characterization of the rat dopamine D4 receptor. Naunyn Schmiedebergs Arch Pharmacol 2000;361:555-64.
24. Patel S, Chapman KL, Marston D, et al. Pharmacological and functional characterization of dopamine D4 receptors in the rat retina. Neuropharmacol 2003;44:1038-46.